240 related articles for article (PubMed ID: 32101122)
1. Anti-Amyloid Aggregating Gold Nanoparticles: Can they Really be Translated from Bench to Bedside for Alzheimer's Disease Treatment?
Shaikh S; Nazam N; Danish Rizvi SM; Hussain T; Farhana A; Choi I
Curr Protein Pept Sci; 2020; 21(12):1184-1192. PubMed ID: 32101122
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
Wu X; Kosaraju J; Zhou W; Tam KY
ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
[TBL] [Abstract][Full Text] [Related]
3. Exploring the Role of Aggregated Proteomes in the Pathogenesis of Alzheimer's Disease.
Narayanan SE; Sekhar N; Rajamma RG; Marathakam A; Al Mamun A; Uddin MS; Mathew B
Curr Protein Pept Sci; 2020; 21(12):1164-1173. PubMed ID: 32957903
[TBL] [Abstract][Full Text] [Related]
4. Anthocyanin-Loaded PEG-Gold Nanoparticles Enhanced the Neuroprotection of Anthocyanins in an Aβ
Ali T; Kim MJ; Rehman SU; Ahmad A; Kim MO
Mol Neurobiol; 2017 Oct; 54(8):6490-6506. PubMed ID: 27730512
[TBL] [Abstract][Full Text] [Related]
5. Nanogold Neuroprotection in Human Neural Stem Cells Against Amyloid-beta-induced Mitochondrial Dysfunction.
Chiang MC; Nicol CJB; Cheng YC; Yen C; Lin CH; Chen SJ; Huang RN
Neuroscience; 2020 May; 435():44-57. PubMed ID: 32229231
[TBL] [Abstract][Full Text] [Related]
6. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
[TBL] [Abstract][Full Text] [Related]
7. RVG29-Functionalized Lipid Nanoparticles for Quercetin Brain Delivery and Alzheimer's Disease.
Pinheiro RGR; Granja A; Loureiro JA; Pereira MC; Pinheiro M; Neves AR; Reis S
Pharm Res; 2020 Jul; 37(7):139. PubMed ID: 32661727
[TBL] [Abstract][Full Text] [Related]
8. Peripheral treatment with enoxaparin exacerbates amyloid plaque pathology in Tg2576 mice.
Cui H; King AE; Jacobson GA; Small DH
J Neurosci Res; 2017 Apr; 95(4):992-999. PubMed ID: 27546887
[TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein: a role in the export of amyloid-β in Alzheimer's disease?
Chai AB; Leung GKF; Callaghan R; Gelissen IC
FEBS J; 2020 Feb; 287(4):612-625. PubMed ID: 31750987
[TBL] [Abstract][Full Text] [Related]
10. Pre-Clinical Neuroprotective Evidences and Plausible Mechanisms of Sulforaphane in Alzheimer's Disease.
Kim J
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805772
[TBL] [Abstract][Full Text] [Related]
11. A Curcumin Analog Exhibits Multiple Biologic Effects on the Pathogenesis of Alzheimer's Disease and Improves Behavior, Inflammation, and β-Amyloid Accumulation in a Mouse Model.
Su IJ; Chang HY; Wang HC; Tsai KJ
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751716
[TBL] [Abstract][Full Text] [Related]
12. Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease.
Uddin MS; Kabir MT; Niaz K; Jeandet P; Clément C; Mathew B; Rauf A; Rengasamy KRR; Sobarzo-Sánchez E; Ashraf GM; Aleya L
Molecules; 2020 Mar; 25(6):. PubMed ID: 32168835
[TBL] [Abstract][Full Text] [Related]
13. Impact of Gold Nanoparticles on Amyloid β-Induced Alzheimer's Disease in a Rat Animal Model: Involvement of STIM Proteins.
Sanati M; Khodagholi F; Aminyavari S; Ghasemi F; Gholami M; Kebriaeezadeh A; Sabzevari O; Hajipour MJ; Imani M; Mahmoudi M; Sharifzadeh M
ACS Chem Neurosci; 2019 May; 10(5):2299-2309. PubMed ID: 30933476
[TBL] [Abstract][Full Text] [Related]
14. Gold nanoparticle-capped mesoporous silica-based H
Yang L; Yin T; Liu Y; Sun J; Zhou Y; Liu J
Acta Biomater; 2016 Dec; 46():177-190. PubMed ID: 27619837
[TBL] [Abstract][Full Text] [Related]
15. Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer's Disease.
Behl T; Kaur I; Fratila O; Brata R; Bungau S
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050199
[TBL] [Abstract][Full Text] [Related]
16. Recent approaches targeting beta-amyloid for therapeutic intervention of Alzheimer's disease.
Cho JE; Kim JR
Recent Pat CNS Drug Discov; 2011 Sep; 6(3):222-33. PubMed ID: 21834780
[TBL] [Abstract][Full Text] [Related]
17. On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis.
Castello MA; Soriano S
Ageing Res Rev; 2014 Jan; 13():10-2. PubMed ID: 24252390
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
19. Are N- and C-terminally truncated Aβ species key pathological triggers in Alzheimer's disease?
Dunys J; Valverde A; Checler F
J Biol Chem; 2018 Oct; 293(40):15419-15428. PubMed ID: 30143530
[TBL] [Abstract][Full Text] [Related]
20. Gold-nanoparticle-based multifunctional amyloid-β inhibitor against Alzheimer's disease.
Gao N; Sun H; Dong K; Ren J; Qu X
Chemistry; 2015 Jan; 21(2):829-35. PubMed ID: 25376633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
